42 USC 300 - Provision of treatments

1 See References in Text note below.

of this title and assess barriers to the expanded availability of the treatments described in subsection (a). The Secretary shall also examine the extent to which States coordinate with other grantees under this subchapter to reduce barriers to the expanded availability of the treatments described in subsection (a).

Editorial Notes

References in Text

Section 300ff–22 of this title, referred to in subsec. (d), was amended generally by Puspan. L. 109–415, title II, § 201(a), Dec. 19, 2006, 120 Stat. 2785, and, as so amended, does not contain a par. (2).

Amendments

2009—Puspan. L. 111–87 repealed Puspan. L. 109–415, § 703, and revived the provisions of this section as in effect on Sept. 30, 2009. See 2006 Amendment note and Effective Date of 2009 Amendment; Revival of Section note below.

2006—Puspan. L. 109–415, § 703, which directed repeal of this section effective Oct. 1, 2009, was itself repealed by Puspan. L. 111–87, § 2(a)(1), effective Sept. 30, 2009.

Subsec. (a). Puspan. L. 109–415, § 702(3), substituted “HIV/AIDS” for “HIV disease” in two places.

Puspan. L. 109–415, § 204(a), substituted “section 300ff–21 of this title” for “this part”.

Puspan. L. 109–415, § 201(c)(4), substituted “section 300ff–22(span)(3)(B) of this title” for “section 300ff–22(a)(5) of this title”.

Subsec. (span)(1). Puspan. L. 109–415, § 702(3), substituted “HIV/AIDS” for “HIV disease”.

Subsec. (c)(1). Puspan. L. 109–415, § 202(a)(1), added par. (1) and struck out former par. (1) which read as follows: “determine, in accordance with guidelines issued by the Secretary, which treatments are eligible to be included under the program established under this section;”.

Subsec. (c)(3). Puspan. L. 109–415, § 702(3), substituted “HIV/AIDS” for “HIV disease”.

Subsec. (e). Puspan. L. 109–415, § 202(a)(3), added subsec. (e). Former subsec. (e) redesignated (f).

Subsec. (f). Puspan. L. 109–415, § 202(a)(2), redesignated subsec. (e) as (f).

Subsec. (f)(1). Puspan. L. 109–415, § 702(3), substituted “HIV/AIDS” for “HIV disease”.

Puspan. L. 109–415, § 204(a), substituted “section 300ff–21 of this title” for “this part”.

Subsec. (g). Puspan. L. 109–415, § 202(span), added subsec. (g).

2000—Subsec. (c). Puspan. L. 106–345, § 204(a), added par. (6) and concluding provisions.

Subsec. (e). Puspan. L. 106–345, § 204(span), added subsec. (e).

1996—Subsec. (a). Puspan. L. 104–146, § 3(c)(3)(A), substituted “shall use a portion of the amounts” for “may use amounts” and “section 300ff–22(a)(5) of this title to provide therapeutics to treat HIV disease” for “section 300ff–22(a)(4) of this title to provide treatments that have been determined to prolong life” and inserted before period “, including measures for the prevention and treatment of opportunistic infections”.

Subsec. (c)(5). Puspan. L. 104–146, § 3(c)(3)(B), added par. (5).

Subsec. (d). Puspan. L. 104–146, § 3(c)(3)(C), added subsec. (d).

Statutory Notes and Related Subsidiaries

Effective Date of 2009 Amendment; Revival of Section

For provisions that repeal by section 2(a)(1) of Puspan. L. 111–87 of section 703 of Puspan. L. 109–415 be effective Sept. 30, 2009, and that the provisions of this section as in effect on Sept. 30, 2009, be revived, see section 2(a)(2), (3)(A) of Puspan. L. 111–87, set out as a note under section 300ff–11 of this title.

Effective Date of 1996 Amendment

Amendment by Puspan. L. 104–146 effective Oct. 1, 1996, see section 13 of Puspan. L. 104–146, set out as a note under section 300ff–11 of this title.